Literature DB >> 12786806

Transcranial Doppler ultrasonography in siblings with sickle cell disease.

Janet L Kwiatkowski1, Jill V Hunter, Kim Smith-Whitley, Mira L Katz, Justine Shults, Kwaku Ohene-Frempong.   

Abstract

The risk of stroke in sickle cell disease (SCD) may be influenced by either genetic or environmental factors. Elevated blood flow velocity in the large cerebral arteries, detected by transcranial Doppler (TCD) ultrasonography, predicts an increased stroke risk in children with SCD. We undertook this study to investigate the possibility of a familial predisposition to elevated cerebral blood flow velocity, a surrogate marker for stroke risk. We analysed the results of TCD studies performed on 63 children from 29 families that had more than one child with SCD. We assessed the association of elevated cerebral blood flow velocity with sibling TCD results as well as age and haemoglobin level, which are factors known to affect cerebral blood flow velocity. Positive or negative TCD results were highly correlated between family members (r = 0.61). The presence of a sibling with a positive TCD result was significantly associated with an elevated cerebral blood flow velocity in other siblings with SCD (odds ratio = 50.7, 95% confidence interval 10.1-253.7, P < 0.001). Furthermore, children who had a sibling with a positive TCD result had a significantly higher TCD velocity than children with SCD but without a sibling who were matched for age, sex, genotype and haemoglobin level. Our results are consistent with a familial predisposition to cerebral vasculopathy in SCD.

Entities:  

Mesh:

Year:  2003        PMID: 12786806     DOI: 10.1046/j.1365-2141.2003.04276.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Genetic predictors for stroke in children with sickle cell anemia.

Authors:  Jonathan M Flanagan; Denise M Frohlich; Thad A Howard; William H Schultz; Catherine Driscoll; Ramamoorthy Nagasubramanian; Nicole A Mortier; Amy C Kimble; Banu Aygun; Robert J Adams; Ronald W Helms; Russell E Ware
Journal:  Blood       Date:  2011-04-22       Impact factor: 22.113

Review 2.  The search for genetic modifiers of disease severity in the β-hemoglobinopathies.

Authors:  Guillaume Lettre
Journal:  Cold Spring Harb Perspect Med       Date:  2012-10-01       Impact factor: 6.915

3.  Genetic mapping and exome sequencing identify 2 mutations associated with stroke protection in pediatric patients with sickle cell anemia.

Authors:  Jonathan M Flanagan; Vivien Sheehan; Heidi Linder; Thad A Howard; Yong-Dong Wang; Carolyn C Hoppe; Banu Aygun; Robert J Adams; Geoffrey A Neale; Russell E Ware
Journal:  Blood       Date:  2013-02-19       Impact factor: 22.113

Review 4.  The paediatric overview.

Authors:  Stuart H Green
Journal:  Pediatr Radiol       Date:  2003-11-28

Review 5.  Genetics of Sickle Cell-Associated Cardiovascular Disease: An Expert Review with Lessons Learned in Africa.

Authors:  Amy Geard; Gift D Pule; David Chelo; Valentina Josiane Ngo Bitoungui; Ambroise Wonkam
Journal:  OMICS       Date:  2016-10

Review 6.  Genetic, laboratory and clinical risk factors in the development of overt ischemic stroke in children with sickle cell disease.

Authors:  André Rolim Belisário; Célia Maria Silva; Cibele Velloso-Rodrigues; Marcos Borato Viana
Journal:  Hematol Transfus Cell Ther       Date:  2017-11-26

Review 7.  Sickle cell disease and H3Africa: enhancing genomic research on cardiovascular diseases in African patients.

Authors:  Ambroise Wonkam; Julie Makani; Solomon Ofori-Aquah; Obiageli E Nnodu; Marsha Treadwell; Charmaine Royal; Kwaku Ohene-Frempong
Journal:  Cardiovasc J Afr       Date:  2015 Mar-Apr       Impact factor: 0.802

8.  Pattern of Cerebral Blood Flow Velocity Using Transcranial Doppler Ultrasonography in Children with Sickle Cell Disorder in Lagos State, Nigeria.

Authors:  Motunrayo Oluwabukola Adekunle; Adeola Barakat Animasahun; Ijeoma Nnenna Diaku-Akinwumi; Olisamedua Fidelis Njokanma
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-08-14       Impact factor: 2.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.